VICTORIA, B.C., May 17, 2006 - CardioComm Solutions Inc. (TSX-V:CCG) ("CardioComm", the "Company"), is pleased to announce that it has formed a strategic alliance with Minneapolis-based QRS Diagnostic, LLC ("QRS"). CardioComm has partnered with QRS to seamlessly incorporate their 12 lead ECG device called Universal ECGT for use within the suite of CardioComm's software platforms. This collaboration is well timed as CardioComm is in final development of an expanded full 12 lead ECG Management module to be incorporated into the Company's web based GlobalCardioT.

CardioComm will be launching GlobalCardio in a wider ECG Management market on a fee for service basis, in addition to the traditional upfront license fee which shall be introduced later this year. This is a positive development for physicians who will have the opportunity to access patient cardiology data from anywhere using the Internet. QRS will be participating in this launch and is a key partner in our efforts to offer cost efficient technology solutions to physicians.

"We are very enthused about our alliance with CardioComm," says QRS founder and CEO, Spencer Lien. "The integration of our diagnostic 12-lead ECG with their software systems will greatly expand our market, providing advanced ECG management capabilities to physicians worldwide. This is another great example of a business partner using the QRS Developer's Kit to rapidly create a unique solution."

About QRS Diagnostic, LLC

Founded in 1994, QRS Diagnostic, Plymouth , Minnesota , uses its patented technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring. The company's PC Card and USB technology platform turns handheld PDAs, laptops, or desktop PCs into modular and upgradeable medical devices, including electrocardiographs, spirometers, pulse oximeters, and vital signs monitors. QRS devices communicate with the company's Office MedicT software platform enabling physicians to cost-effectively perform diagnostic procedures on off-the-shelf computer hardware. The affordability, durability and mobility of QRS devices also advance patient monitoring in home health care and disease management. The company's products are FDA cleared, CE Marked, and available in seven languages. For more information on QRS, please visit www.QRSdiagnostic.com.

About CardioComm Solutions Inc.

CardioComm's patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (ECGs), for diagnosis and management of cardiac patients. The Company's products are sold worldwide through a combination of its external distribution network and its North American based sales team. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time ECG viewer. CardioComm is the first company to provide a real-time means of viewing ECGs over a network (LAN, WAN or Internet). This tool enables ECGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as Global ECG Management System (GEMST) and GlobalCardioT. CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has earned the latest ISO 13485 certification.